Samuel T. Wilkinson, MD

home / authors / samuel-t-wilkinson-md

Articles

Electroconvulsive Therapy for the Treatment of Dementia Symptoms

T. Greg Rhee, PhD;Samuel T. Wilkinson, MD

October 14th 2024

Experts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.

The Effects of Multidose Ketamine Treatment on Cognitive Performance Over Time in Patients With TRD

Kristina T. Kumpf, MA;Brian Pittman, MS;Samuel T. Wilkinson, MD

June 25th 2024

Experts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.

What is the efficacy of ECT for the treatment of dementia?

Electroconvulsive Therapy in Individuals with Behavioral and Psychological Symptoms of Dementia

T. Greg Rhee, PhD;Samuel T. Wilkinson, MD

April 22nd 2024

What is the efficacy of ECT for the treatment of dementia?

What Is the Deal With Esketamine?

Samuel T. Wilkinson, MD

April 6th 2020

Samuel T. Wilkinson, MD, discusses the risks and benefits, as well as the challenges of clinical implementation of esketamine, for treatment-resistant depression.

Latest Updated Articles

Published: March 19th 2021 | Updated: February 5th 2025

Mini Quiz: Treatment for Pedophilia?

Published: September 17th 2024 | Updated: February 5th 2025

The Role of Psychiatric Nurse Practitioner Clinical Placements in Shaping the Future of Care

Published: January 29th 2025 | Updated: February 5th 2025

APSARD 2025 Highlights New Frontiers, New Findings at Annual Conference

Published: January 30th 2025 | Updated: February 5th 2025

Yale-Led Study Will Compare Effectiveness of IV Ketamine and Esketamine Nasal Spray

Published: January 31st 2025 | Updated: February 5th 2025

Study Sheds Light on Social Drivers That Increase Risk of Suicide

Published: March 23rd 2021 | Updated: February 5th 2025

Poor DSM-5—So Misunderstood!

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777